We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
-1.91%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$151M
AUM Growth
+$10.1M
Cap. Flow
+$16.3M
Cap. Flow %
10.8%
Top 10 Hldgs %
48.77%
Holding
155
New
39
Increased
47
Reduced
18
Closed
28

Top Buys

Rank Stock Value
1
CPNG icon
Coupang
CPNG
+$8.86M
2
KSU
Kansas City Southern
KSU
+$3.59M
3
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$3.54M
4
PPD
PPD, Inc. Common Stock
PPD
+$3.47M
5
FIVN icon
FIVE9
FIVN
+$3.18M

Top Sells

Rank Stock Value
1
WTW icon
Willis Towers Watson
WTW
+$9.44M
2
MXIM
Maxim Integrated Products
MXIM
+$4.49M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$3.96M
4
WORK
Slack Technologies, Inc.
WORK
+$3.57M
5
SOGO
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
+$3.07M

Sector Composition

Rank Sector Weight
1 Healthcare 44.08%
2 Technology 31.3%
3 Consumer Discretionary 7.05%
4 Communication Services 3.66%
5 Industrials 2.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SMSI icon
126
Smith Micro Software
SMSI
$16.6M
$57K 0.04%
293
– –
GNSS icon
127
Genasys
GNSS
$76.1M
$55K 0.04%
10,721
– –
BCRX icon
128
BioCryst Pharmaceuticals
BCRX
$2.64B
– –
-15,316
Closed -$242K
DOYU
129
DouYu International Holdings
DOYU
$139M
– –
-24,960
Closed -$1.71M
GNE icon
130
Genie Energy
GNE
$384M
– –
-15,465
Closed -$97K
IDT icon
131
IDT Corp
IDT
$1.63B
– –
-6,549
Closed -$242K
KYMR icon
132
Kymera Therapeutics
KYMR
$9.11B
– –
-18,587
Closed -$901K
MCRB icon
133
Seres Therapeutics
MCRB
$46.6M
– –
-2,238
Closed -$1.07M
MNKD icon
134
MannKind Corp
MNKD
$1.23B
– –
-23,080
Closed -$126K
MRSN
135
DELISTED
Mersana Therapeutics
MRSN
– –
-2,396
Closed -$814K
NKTX icon
136
Nkarta
NKTX
$167M
– –
-30,419
Closed -$964K
NTLA icon
137
Intellia Therapeutics
NTLA
$1.68B
– –
-3,685
Closed -$597K
QNST icon
138
QuinStreet
QNST
$1.2B
– –
-12,301
Closed -$229K
RMNI icon
139
Rimini Street
RMNI
$449M
– –
-15,097
Closed -$93K
FLNA
140
Filana Therapeutics
FLNA
$46.9M
– –
-2,488
Closed -$212K
TLYS icon
141
Tilly's
TLYS
$127M
– –
-13,109
Closed -$209K
WTW icon
142
Willis Towers Watson
WTW
$31.8B
– –
-41,056
Closed -$9.44M
ZYME icon
143
Zymeworks
ZYME
$1.73B
– –
-25,452
Closed -$883K
IVAC
144
DELISTED
Intevac Inc
IVAC
– –
-11,530
Closed -$78K
ITI
145
DELISTED
Iteris, Inc.
ITI
– –
-14,017
Closed -$93K
OSG
146
DELISTED
Overseas Shipholding Group Inc.
OSG
– –
-26,400
Closed -$55K
ALR
147
DELISTED
AlerisLife Inc
ALR
– –
-17,807
Closed -$102K
SRNE
148
DELISTED
Sorrento Therapeutics, Inc.
SRNE
– –
-18,000
Closed -$174K
TRIL
149
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-94,478
Closed -$916K
NNA
150
DELISTED
Navios Maritime Acquisition Corporation
NNA
– –
-21,215
Closed -$72K
3 4 5
6
7

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
PPG
Peak Planning Group Centennial, Colorado $361M AUM 22.01% 1-Year Est. Return
PWC
PYA Waltman Capital Knoxville, Tennessee $361M AUM 9.49% 1-Year Est. Return

HighVista Strategies's Q3 2021 Portfolio in Review

As of Q3 2021, HighVista Strategies held 155 positions worth $151M, up 7.2% from $141M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

HighVista Strategies deployed $16.3M of net new capital in Q3 2021, opening 39 new positions and adding to 47 existing holdings. Its largest new stake was Coupang: 256,264 shares worth $7.14M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Alibaba, an estimated $1.39M trimmed.

  • HighVista Strategies's largest Q3 2021 buy was Coupang: 256,264 shares worth $7.14M.
  • HighVista Strategies added most to ESSA Pharma in Q3 2021, an estimated $1.9M increase.
  • HighVista Strategies's biggest Q3 2021 reduction was Alibaba, cutting an estimated $1.39M.
  • HighVista Strategies fully exited Willis Towers Watson in Q3 2021, selling an estimated $9.44M.
  • HighVista Strategies's ten largest holdings make up 49% of its $151M portfolio in Q3 2021.
  • HighVista Strategies opened 39 new positions and closed 28 in Q3 2021.
  • HighVista Strategies's portfolio value rose 7.2% quarter-over-quarter to $151M.

Based on HighVista Strategies's 13F filing for Q3 2021, filed 15 Nov 2021.